Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapoxetine Combinations for Refractory Premature Ejaculation
NCT04703127Phase 3Unknown
- Sponsor
- Sohag University
- Start
- Mar 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil, lidocaine 10% oropharyngeal spray in premature ejaculation (PE), sponsored by Sohag University. Status: unknown.
02
Drugs
tadalafillidocaine 10% oropharyngeal spray
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT04703127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04703127.